欧洲白细胞去除术市场预测至 2028 年 - COVID-19 影响和按产品类型(白细胞去除术设备和白细胞去除术一次性用品)、应用(研究应用和治疗应用)和最终用户(血液成分提供商和血液中心、学术和研究机构、制药和生物技术公司、医院和输血中心)

TIPRE00025790 | Pages: 132 | Pharmaceuticals | Nov 2021 | Type: Regional | Status: Published

市场介绍

欧洲白细胞分离术市场基于三个大国进行分析:德国、英国、法国、意大利、西班牙和鱼子。德国在白细胞分离术市场的增长中贡献了主要份额。德国因其稳定的增长和创新的医疗保健方法而成为一个有吸引力的市场。据联邦统计局统计,2019年德国卫生支出达4600.3亿美元。德国医疗器械市场是欧洲最大的医疗器械市场之一,也是世界第三大医疗器械市场。全球对高度创新技术以及诊断、治疗和微创设备的需求仍然很高。德国的医疗器械制造商还可以为各种研究项目申请国家资助,并获得重建贷款公司(KfW)的资助。制造商越来越关注新产品开发和战略合作以开发白细胞分离术等先进诊断设备,预计将推动市场增长。德国拥有强大的卫生系统,特别是基础设施、病床和训练有素的工作人员。据卫生部称,2018年,1,925家医院、1,142家康复中心和19,075家药房拥有近498,400张床位。发达的基础设施使拥有560万员工的健康产业成为德国最大的雇主。 2016 年,德国约有 13,900 人患上白血病,其中 4% 年龄在 15 岁以下。在进入青年期的过程中,这种风险会降低,但从 30 岁开始又会再次增加。男性的发病率高于女性。每 67 名男性和每 87 名女性中就有 1 人会在一生中的某个阶段患上白血病。

由于该地区 COVID-19 病例呈指数级增长,欧洲经济受到严重影响。俄罗斯、西班牙、意大利、德国、法国和英国是受影响最严重的欧洲国家。欧洲各国在今年年初成功缓解疫情后,Covid-19 病例再次出现。许多国家现在每天宣布的病例数量比今年早些时候第一波疫情期间还要多。根据欧洲疾病预防和控制中心 (ECDC) 的数据,英国、西班牙、意大利和爱尔兰正在重新实施封锁。由于第二波 COVID-19 病例,许多国家的政府正在努力扩大检测能力,这正在推动市场的增长。

市场概况和动态

欧洲白细胞分离术市场预计将从2021年的2255万美元增长到2028年的3926万美元;预计 2021 年至 2028 年复合年增长率为 8.2%。治疗性单采术是指一种体外治疗,涉及选择性去除血液循环中的细胞或其他有针对性的异常物质。最近,该技术已被探索用于治疗各种医疗状况。体外光采术(ECP)是一种用于治疗淋巴瘤的方法。在此过程中,从血液中收集白细胞(WBC),用光激活药物进行处理,并暴露在紫外线下,然后将其输回患者体内。治疗性血浆置换是治疗多发性硬化症、骨髓瘤和白血病等疾病的潜在方法。该技术从患者的血液中抽取血浆,并用新鲜的供体血浆或瓶装人白蛋白溶液代替。此外,双重过滤血浆置换技术用于快速进展性肾小球肾炎,低密度脂蛋白(LDL)血浆置换术或白细胞置换术用于肾病综合征。这些技术是用于治疗肾脏疾病的两种主要的单采疗法。因此,单采技术在治疗领域的广泛应用正在成为白细胞分离市场的普遍趋势。

关键市场细分

<从产品类型来看,2021年白细胞分离一次性用品细分市场占有较大份额。从应用来看,2021年研究应用细分市场占有最大份额。基于最终用户,血液成分提供商和血液中心细分市场在 2021 年占据最大份额。

主要来源和上市公司

<准备本欧洲白细胞分离术市场报告时参考的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件和统计数据库等。报告中列出的主要公司有:旭化成株式会社;费森尤斯公司两合公司;血液公司;泰尔茂公司; STEMCELL 技术公司;赫马护理;玛科制药公司;所有细胞;干快递;和 BioIVT 等

购买报告的理由

  • 了解欧洲白细胞分离术市场格局,并确定最有可能保证丰厚回报的细分市场
  • 通过了解不断变化的竞争格局,保持领先地位欧洲白细胞分离术市场格局
  • 通过识别最有可能销售前景的细分市场,有效规划欧洲白细胞分离术市场的并购和合作伙伴交易
  • 帮助通过敏锐的洞察力和洞察力做出明智的业务决策全面分析欧洲白细胞分离术市场各个细分市场的市场表现
  • 获取欧洲地区2021-2028年各个细分市场的市场收入预测

 

欧洲白细胞分离术市场细分

 

欧洲白细胞去除术市场 –按产品类型

  • 白细胞去除一次性用品
  • 白细胞去除设备

欧洲白细胞去除术市场 –按应用

  • 研究应用
  • 治疗应用

欧洲白细胞分离术市场——按产品类型

  • 血液成分提供商和血液中心
  • 医院和输血中心
  • 制药和生物技术公司
  • 学术和研究机构

 

欧洲白细胞分离市场 -按国家/地区

  • 德国
  • 英国
  • 法国
  • 意大利
  • 西班牙
  • 欧洲其他地区

欧洲白细胞去除术市场 -提及的公司

  • 旭化成株式会社              
  • Fresenius SE &                    ;         
  • Haemonetics Corporation              
  • 泰尔茂株式会社                         ;         
  • STEMCELL Technologies Inc.         ;              
  • HemaCare  
  • Macopharma
  • AllCells
  • STEMEXPRESS
  • BioIVT                           

TABLE OF CONTENTS

1.          Introduction

1.1        Scope of the Study

1.2        The Insight Partners Research Report Guidance

1.3        Market Segmentation

1.3.1        Europe Leukapheresis Market – By Product Type

1.3.2        Europe Leukapheresis Market – By Application

1.3.3        Europe Leukapheresis Market – By End User

1.3.4        Europe Leukapheresis Market – By Country

2.          Europe Leukapheresis Market – Key Takeaways

3.          Research Methodology

3.1        Coverage

3.2        Secondary Research

3.3        Primary Research

4.          Europe Leukapheresis Market – Market Landscape

4.1        Overview

4.2        PEST Analysis

4.3        Expert Opinions

5.          Europe Leukapheresis Market – Key Market Dynamics

5.1        Market Drivers

5.1.1        Elevating Number of Voluntary Blood Donors

5.1.2        Growing Incidence of Hematologic Diseases

5.1.3        Scaling Elderly Population

5.2        Key Market Restraints

5.2.1        Heavy Cost of Leukapheresis

5.3        Key Market Opportunities

5.3.1        Boosting Opportunities in Emerging Economies

5.4        Future Trends

5.4.1        Advancements in Therapeutic Apheresis

5.5        Impact Analysis

6.          Europe Leukapheresis – Market Analysis

6.1        Europe Leukapheresis Market Revenue Forecast and Analysis

7.          Europe Leukapheresis Market Analysis – by Product Type

7.1        Overview

7.2        Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)

7.3        Leukapheresis Devices

7.3.1        Overview

7.3.2        Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.1          Apheresis Devices

7.3.2.1.1          Overview

7.3.2.1.2          Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.2          Leukapheresis ColuMillions and Cell Separators

7.3.2.2.1          Overview

7.3.2.2.2          Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)

7.3.2.3          Leukoreduction Filters

7.3.2.3.1          Overview

7.3.2.3.2          Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)

7.4        Leukapheresis Disposables

7.4.1        Overview

7.4.2        Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)

8.          Europe Leukapheresis Market Analysis – by Application

8.1        Overview

8.2        Europe Leukapheresis Market Share by Application 2021 & 2028 (%)

8.3        Research Applications

8.3.1        Overview

8.3.2        Research Applications Market Revenue and Forecast to 2028 (US$ Million)

8.4        Therapeutic Applications

8.4.1        Overview

8.4.2        Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)

9.          Europe Leukapheresis Market Analysis – by End-User

9.1        Overview

9.2        Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)

9.3        Pharmaceutical and Biotechnology Companies

9.3.1        Overview

9.3.2        Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)

9.4        Blood Component Providers and Blood Centers

9.4.1        Overview

9.4.2        Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)

9.5        Academic and Research Institutes

9.5.1        Overview

9.5.2        Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)

9.6        Hospitals and Transfusion Centers

9.6.1        Overview

9.6.2        Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)

10.       Europe Leukapheresis Market – Country Analysis

10.1      Overview

10.1.1     Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)

10.1.1.1       Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.1       Overview

10.1.1.1.2       Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.1.3       Germany: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.1.3.1     Germany: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.1.4       Germany: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.1.5       Germany: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.2       France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.2.1       France: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.2.1.1     France: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.2.2       France: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.2.3       France: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.3       UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.1       Overview

10.1.1.3.2       UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.3.3       UK: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.3.3.1     UK: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.3.4       UK: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.3.5       UK: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.4       Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.1       Overview

10.1.1.4.2       Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.4.3       Italy: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.4.3.1     Italy: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.4.4       Italy: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.4.5       Italy : Leukapheresis Market, by End User, 2019-2028 (USD Million)

10.1.1.5       Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.1       Overview

10.1.1.5.2       Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.5.3       Spain: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.5.3.1     Spain: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.5.4       Spain: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.5.5       Spain: Leukapheresis Market, by End User, 2019–2028 (USD Million)

10.1.1.6       Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

10.1.1.6.3       Rest of Europe: Leukapheresis Market, By Product type, 2019–2028 (USD Million)

10.1.1.6.3.1     Rest of Europe: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)

10.1.1.6.4       Rest of Europe: Leukapheresis Market, by Application, 2019–2028 (USD Million)

10.1.1.6.5       Rest of Europe: Leukapheresis Market, by End User, 2019–2028 (USD Million)

11.       Europe Leukapheresis Market – Impact of COVID-19 Pandemic

11.1      Impact Assessment Of COVID-19 Pandemic

12.       Europe Leukapheresis Market – Industry Landscape

12.1      Overview

12.2      Organic Developments

12.2.1     Overview

12.3      Inorganic Developments

12.3.1     Overview

13.       Company Profiles

13.1      Asahi Kasei Corporation

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Fresenius SE & Co. KGaA

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Haemonetics Corporation

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Terumo Corporation

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      STEMCELL Technologies Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      HemaCare

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Macopharma

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      AllCells

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      STEMEXPRESS

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   BioIVT

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.       Appendix

14.1      About the Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.            Germany: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 2.            Germany Leukapheresis Market, by D Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 3.            Germany Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4.            Germany: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 5.            France: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 6.            France Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 7.            France Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 8.            France: Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)

Table 9.            UK: Leukapheresis Market, By Product type– Revenue and Forecast to 2028 (USD Million)

Table 10.          UK Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 11.          UK Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 12.          UK: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 13.          Italy: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 14.          Italy Leukapheresis Market, by Leukapheresis Devices– Revenue and Forecast to 2028 (USD Million)

Table 15.          Italy Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16.          Italy: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 17.          Spain: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 18.          Spain Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 19.          Spain Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 20.          Spain: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 21.          Rest of Europe: Leukapheresis Market, By Product type – Revenue and Forecast to 2028 (USD Million)

Table 22.          Rest of Europe Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)

Table 23.          Rest of Europe Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 24.          Rest of Europe: Leukapheresis Market, by End User– Revenue and Forecast to 2028 (USD Million)

Table 25.          Organic Developments Done by Companies

Table 26.          Inorganic Developments Done by Companies

Table 27.          Glossary of Terms, Leukapheresis Market

LIST OF FIGURES

Figure 1.           Europe Leukapheresis Market Segmentation

Figure 2.           Europe Leukapheresis Market Segmentation, By country

Figure 3.           Europe Leukapheresis Market Overview

Figure 4.           Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market

Figure 5.           Germany to Show Significant Growth During Forecast Period

Figure 6.           Europe Leukapheresis Market, Industry Landscape

Figure 7.           Europe PEST Analysis

Figure 8.           Europe Leukapheresis market impact analysis of driver and restraints

Figure 9.           Europe Leukapheresis Market – Revenue Forecast and Analysis (2021- 2028)

Figure 10.        Europe Leukapheresis Market Share by Product Type 2021 & 2028 (%)

Figure 11.        Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 12.        Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)

Figure 13.        Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)

Figure 14.        Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)

Figure 15.        Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16.        Europe Leukapheresis Market Share by Application 2021 & 2028 (%)

Figure 17.        Research Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18.        Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19.        Europe Leukapheresis Market Share by End-User 2021 & 2028 (%)

Figure 20.        Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21.        Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22.        Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)

Figure 23.        Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)

Figure 24.        Europe: Leukapheresis Market, by Key Country – Revenue (2021) (USD Million)

Figure 25.        Europe: Leukapheresis Market, by Country, 2021 & 2028 (%)

Figure 26.        Germany: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 27.        France: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 28.        UK: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 29.        Italy: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 30.        Spain: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 31.        Rest of Europe: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)

Figure 32.        Impact of COVID-19 Pandemic in European Country Markets

  1. Asahi Kasei Corporation                                 
  2. Fresenius SE & Co. KGaA                                
  3. Haemonetics Corporation                              
  4. Terumo Corporation                                        
  5. STEMCELL Technologies Inc.                          
  6. HemaCare  
  7. Macopharma
  8. AllCells
  9. STEMEXPRESS  
  10. BioIVT 
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe leukapheresis market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Europe leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.


Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000